Search results for "Ship"

showing 10 items of 6731 documents

Exploring the application of blockchain to humanitarian supply chains: insights from Humanitarian Supply Blockchain pilot project

2021

PurposeSome studies and reports have recently suggested using blockchain technology to improve transparency and trust in humanitarian supply chains (HSCs). However, evidence-based studies to display the utility and applicability of blockchains in HSCs are missing in the literature. This paper aims to investigate the key drivers and barriers of blockchain application to HSCs and explore whether evidence could support that the application of blockchain improves transparency and trust in HSCs.Design/methodology/approachThis paper puts forward a two-stage approach to explore the blockchain application in HSCs: an initial exploration of humanitarian practitioners and academicians interested in b…

021103 operations researchBlockchainKnowledge managementbusiness.industryStrategy and ManagementSupply chainCorporate governance05 social sciences0211 other engineering and technologiesGeneral Decision Sciences02 engineering and technologyTransparency (behavior)VDP::Samfunnsvitenskap: 200::Økonomi: 210Management of Technology and InnovationGeneral partnership0502 economics and businessAccountabilityAdded valueBusinessInternational development050203 business & managementInternational Journal of Operations & Production Management
researchProduct

The Integration of the Supply Chain as a Dynamic Capability for Sustainability: The Case of an Innovative Organic Company

2018

Numerous research projects have demonstrated that a firm’s ability to integrate, build, and reconfigure internal and external competencies to adapt to changes in its environment is a key capability for its competitiveness. However, in the case of developing the capabilities needed to implement innovation, we have found that the ability to integrate knowledge into the supply chain is also crucial since it is an essential requirement for bringing in technological change and product innovation. The purpose of this chapter is to understand the role of supplier integration in the implementation of radical innovation. First, we propose a theoretical model to connect supplier integration as a dyna…

021103 operations researchProcess managementProduct innovationTechnological changeSupply chain05 social sciences0211 other engineering and technologies02 engineering and technologyOrder (exchange)General partnership0502 economics and businessSustainabilityKey (cryptography)BusinessDynamic capabilities050203 business & management
researchProduct

From Neo-Functional Peace to a Logic of Spillover in EU External Policy: A Response to Visoka and Doyle

2017

In their recently published JCMS article, Gezim Visoka and John Doyle have proposed the concept of ‘neofunctional peace’ as a means to conceptualize the EU's peacemaking practices in the case of the EU-facilitated Belgrade-Pristina dialogue. This article challenges the ‘neo-functional peace’ on conceptual and empirical grounds. We critically discuss Visoka and Doyle's (2016) reading of neofunctionalism and question parts of their empirical evidence given for the existence of a ‘neo-functional peace’. Going beyond a mere critique of the article by Visoka and Doyle and arguing that the authors may not have fully exploited neofunctionalism's potential for theorizing EU external policy, we stip…

021110 strategic defence & security studiesEconomics and EconometricsEntrepreneurshipbusiness.industry05 social sciences0211 other engineering and technologies02 engineering and technologyInternational tradeGeneral Business Management and Accounting0506 political scienceNeofunctionalismSpillover effectAction (philosophy)Political Science and International RelationsMediationRealm050602 political science & public administrationPeacemakingSociologyBusiness and International ManagementPositive economicsEmpirical evidencebusinessJCMS: Journal of Common Market Studies
researchProduct

The politics of Argentina today: human rights and Kirchnerismo

2016

After the effects of bloody dictatorship that whipped the region, Argentina as many other Latin American countries experienced a great trauma which not only altered the ways politics was lived, but also undermined the social trust of citizens respecting to their institutions. The rise of Kirchneristes and Kirchnerismo post stock and market crisis of 2001, initiated a new age in Argentina. Kirchnerismo opened the doors for the vindication of many claims of human rights organisations, but at the same time, the discourse of human rights was adjusted to the interests of Cristina Kirchner and her followers. As a result of this, the cause of human rights allowed government to produce a new way of…

021110 strategic defence & security studiesLatin AmericansHuman rightsmedia_common.quotation_subject0211 other engineering and technologies021107 urban & regional planning02 engineering and technologyDictatorshipPoliticsPolitical economyLawSociologySocial trustStock (geology)media_commonInternational Journal of Human Rights and Constitutional Studies
researchProduct

The Recent Development of a Sweet-Tasting Brazzein and its Potential Industrial Applications

2016

International audience; Brazzein is a small heat- and pH-stable sweet-tasting protein isolated from the West African plant, Pentadiplandra brazzeana. Brazzein combines a highly sweet potency, a long history of human consumption, and a remarkable stability, giving it great potential as a natural sweetener. Due to the difficulties of obtaining brazzein from its natural source, several efforts have been made to express brazzein using various heterologous expression systems. This chapter describes the biochemical, structural, sensory, and physiological properties of brazzein. We will summarize the current knowledge of the structure-activity relationship of brazzein. The biotechnological product…

0301 basic medicine0106 biological sciences[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutritionreceiver01 natural sciences03 medical and health sciences0404 agricultural biotechnology010608 biotechnologygoût sucréBrazzeinSweet-tasting proteinHigh-potency sweetenersPentadiplandra030304 developmental biology2. Zero hunger0303 health sciencesbiologySweet-taste receptorStructure-function relationshipfood and beverages04 agricultural and veterinary sciencesbiology.organism_classification040401 food scienceWest african[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition030104 developmental biologyprotéinehigh-potency sweetenerNatural sourcebiology.proteinBrazzeinBiochemical engineeringproteinédulcorant intenserécepteur[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

QSPR Prediction of Retention Times of Methylxanthines and Cotinine by Bioplastic Evolution

2018

High-performance liquid-chromatographic retention times of methylxanthines and cotinine in human plasma and urine are modelled by structure–property relationships. Bioplastic evolution is an evolutionary perspective conjugating the effect of acquired characters, and relations that emerge among the principles of evolutionary indeterminacy, morphological determination and natural selection. It is applied to design co-ordination index, which is used to characterize retentions of methylxanthines, etc. Parameters used to calculate co-ordination index are formation enthalpy, molecular weight and surface area. Morphological and co-ordination indices provide strong correlations. Effect of different…

0301 basic medicine03 medical and health scienceschemistry.chemical_compoundQuantitative structure–activity relationship030104 developmental biologyMaterials scienceChromatographychemistry02 engineering and technology021001 nanoscience & nanotechnology0210 nano-technologyCotinineBioplasticInternational Journal of Quantitative Structure-Property Relationships
researchProduct

Investigation of Isoindolo[2,1-a] quinoxaline-6-imines as Topoisomerase I Inhibitors with Molecular Modeling Methods

2017

Background: Isoindolo[2,1-alpha] quinoxalines constitute an important class of compounds which demonstrated potent antiproliferative activity against different human tumor cell lines and topoisomerase I inhibitors. In particular, their water soluble imine or iminium salts recently synthesized showed potent growth inhibitory effect on NCI-60 tumor cell line panel and biological studies performed on the most active compounds demonstrated that they cause DNA damage via topoisomerase I poisoning. Objective: Herein, we investigate with molecular modeling methods, the common features responsible for topoisomerase I inhibition of the water-soluble isoindolo[2,1-alpha] quinoxalin-6-imines, by compa…

0301 basic medicine030103 biophysicsMolecular modelStereochemistryDNA damageAntineoplastic AgentsIsoindolesTopoisomerase-I InhibitorCrystallography X-RayaromatechinStructure-Activity Relationship03 medical and health scienceschemistry.chemical_compoundQuinoxalinetopotecanantiproliferativeCell Line TumorNeoplasmsQuinoxalinesquinoxalineDrug DiscoveryHumansCell Proliferationbiologypharmacophore modelTopoisomeraseIminiumGeneral MedicineSettore CHIM/08 - Chimica FarmaceuticaMolecular Docking SimulationTopoisomerase IindenoisoquinolineDNA Topoisomerases Type IchemistryDocking (molecular)dockingbiology.proteinMolecular MedicineTopoisomerase I; quinoxaline; antiproliferative; topotecan; aromatechin; indenoisoquinoline; docking; pharmacophore modelIminesTopoisomerase I InhibitorsPharmacophore
researchProduct

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

2017

Background: Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. Methods: We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered subcutaneously every 3 months) with placebo. The primary efficacy end point was nonfatal myocardial infarction, …

0301 basic medicine030204 cardiovascular system & hematologylaw.invention0302 clinical medicinec-reactive proteinRandomized controlled triallawCardiovascular Diseasemiddle ageddouble-blind methodantibodiesMyocardial infarctionhumansStrokeinterleukin-1betabiologyAntibodies MonoclonaldrugGeneral MedicineLipidAged; anti-inflammatory agents; antibodies; monoclonal; antibodies; monoclonal; humanized; atherosclerosis; c-reactive protein; cardiovascular diseases; dose-response relationship; drug; double-blind method; female; humans; incidence; infections; interleukin-1beta; lipids; male; middle aged; myocardial infarction; neutropenia; secondary prevention; strokestrokeAnti-Inflammatory AgentagedEditorialfemalemyocardial infarctionAtherosclerosiMonoclonalsecondary preventionHumanmedicine.drugmedicine.medical_specialtymonoclonalNeutropeniaAntibodies Monoclonal HumanizedInfectionsPlaceboaged; anti-inflammatory agents; antibodies monoclonal; atherosclerosis; c-reactive protein; cardiovascular diseases; dose-response relationship drug; double-blind method; female; humans; incidence; infection; interleukin-1beta; lipids; male; middle aged; myocardial infarction; neutropenia; secondary prevention; stroke; medicine (all)anti-inflammatory agentsdose-response relationshiplipids03 medical and health sciencesmaleInternal medicinemedicineneutropeniamedicine (all)Dose-Response Relationship Drugbusiness.industryAntiinflammatory Therapy Canakinumab for Atherosclerotic DiseaseC-reactive proteinmedicine.diseaseinfectioncardiovascular diseasesSurgeryCanakinumab030104 developmental biologyincidencebiology.proteinatherosclerosisbusinessNew England journal of medicine
researchProduct

2,3-Dihydrobenzofuran privileged structures as new bioinspired lead compounds for the design of mPGES-1 inhibitors

2016

International audience; 2,3-Dihydrobenzofurans are proposed as privileged structures and used as chemical platform to design small compound libraries. By combining molecular docking calculations and experimental verification of biochemical interference, we selected some potential inhibitors of microsomal prostaglandin E2 synthase (mPGES)-1. Starting from low affinity natural product 1, by our combined approach we identified the compounds 19 and 20 with biological activity in the low micromolar range. Our data suggest that the 2,3-dihydrobenzofuran derivatives might be suitable bioinspired lead compounds for development of new generation mPGES-1 inhibitors with increased affinity.

0301 basic medicine300323-Dihydrobenzofuran privileged structure; Cancer; Inflammation; Molecular docking; mPGES-1 inhibitors; Biochemistry; Clinical Biochemistry; Molecular Biology; Molecular Medicine; Organic Chemistry; Drug Discovery3003 Pharmaceutical Science; 3003Amino Acid MotifsClinical BiochemistryGene ExpressionPharmaceutical Science01 natural sciencesClinical biochemistryBiochemistry[ CHIM ] Chemical SciencesProtein Structure Secondary[ SDV.CAN ] Life Sciences [q-bio]/Cancerchemistry.chemical_compoundLow affinityDrug DiscoveryEnzyme Inhibitors23-Dihydrobenzofuran privileged structure; Molecular docking; mPGES-1 inhibitors; Cancer; InflammationProstaglandin-E SynthasesCancerAnti-Inflammatory Agents Non-SteroidalBiological activityProto-Oncogene Proteins c-metIntramolecular OxidoreductasesMolecular Docking SimulationMolecular dockingMolecular Medicinelipids (amino acids peptides and proteins)Cell SurvivalStereochemistryMolecular Sequence Data2Antineoplastic Agents[SDV.CAN]Life Sciences [q-bio]/Cancer3-Dihydrobenzofuran privileged structureInhibitory Concentration 50Structure-Activity Relationship03 medical and health sciencesCell Line TumorMicrosomesHumans[CHIM]Chemical SciencesMolecular BiologyBenzofuransInflammationNatural product010405 organic chemistryDrug Discovery3003 Pharmaceutical ScienceOrganic ChemistryEpithelial CellsmPGES-1 inhibitorsCombinatorial chemistryCombined approach0104 chemical sciences030104 developmental biologychemistryDrug DesignDrug Screening Assays Antitumor
researchProduct

Therapeutic drug monitoring as a tool to optimize 5-FU-based chemotherapy in gastrointestinal cancer patients older than 75 years.

2019

Abstract Aims Most clinical trials exclude elderly people, leading to a limited understanding of the benefit-to-risk ratio in this population. Despite existing data regarding the oncological management of elderly receiving fluorouracil (5-FU)-based regimen, our objective was to investigate 5-FU exposure/toxicity relationship in patients ≥75 years and compare the effectiveness of 5-FU therapeutic drug monitoring between elderly and younger patients. Methods Hundred fifty-four patients (31 of whom are older than 75 years) with gastrointestinal cancers, who were to receive 5-FU–based regimens, were included in our study. At cycle 1 (C1), the 5-FU dose was calculated using patient's body surfac…

0301 basic medicineAdultMaleCancer Researchmedicine.medical_specialty[SDV]Life Sciences [q-bio]PopulationAntineoplastic Agents03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansGastrointestinal cancereducationAgedGastrointestinal NeoplasmsRetrospective StudiesBody surface areaAged 80 and overeducation.field_of_studymedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryArea under the curveMiddle Agedmedicine.disease3. Good healthClinical trialRegimen030104 developmental biologyOncologyTolerabilityTherapeutic drug monitoring030220 oncology & carcinogenesisFemaleFluorouracilDrug MonitoringbusinessEuropean journal of cancer (Oxford, England : 1990)
researchProduct